RALEIGH, North Carolina, May 12 /PRNewswire/ --
PRA International, a leading Clinical Research Organization, announces it is participating as a sponsor for Exploratory Clinical Development World (ECDW), 13-14 May 2009, in London, UK. ECDW is considered to be Europe's largest and most highly regarded early development congress. Experts from PRA's Early Development Services (EDS) group will be available to discuss PRA's capabilities at ECDW. Please contact Martin Schuiling ( email@example.com) to schedule a meeting and learn more.
With harmonized clinical and laboratory facilities, 228 beds in Europe and the US and an innovative Early Development model that brings the center to the patients in Central/Eastern Europe, PRA's EDS group provides comprehensive services for Phase I and Phase IIa studies. PRA's integrated data support, in-house pharmacy and expedited regulatory approval timelines in The Netherlands enable PRA to reduce timelines for sponsors.
About PRA International
PRA International is a global Clinical Research Organization providing services through all phases of clinical development. We perform studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. PRA has supported over 2,100 clinical trials through its 35 global offices. PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.
Roger Boutin, Director of Marketing, PRA International, Inc., +1-434-951-3924